Beacons of the Start-up Scene, part 5: MIR Insight
Tapping into Future-oriented Synergies of Data Analysis in the Materials Sector
Interview mit Bjol R. Frenkenberger, MIR Insight
Since its launch in 2019, the CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has provided more than 100 start-ups from over 15 countries with the opportunity to present their innovative ideas, products and technologies to a broad target group. We are taking this milestone as an opportunity to look back at some of the start-up stories of the past six years and highlight their development.
In this issue: MIR Insight. Founded in 2021 and based in Oslo, Norway, the company offers its customers data-driven forecasts created with the help of AI for accurate, dynamic demand forecasting. Co-founder and CEO Bjol R. Frenkenberger explainswhat has happened since its launch in December 2022 .
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
Company
MIR Insight ASGaustadalléen 21
0349 Oslo
Norway
most read

Q1 2025 Chemical Industry: Diverging Trends
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

Specialty Chemicals in a Shifting World
Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

“Access to Talent is a Crucial Factor”
In an interview with CHEManager, Edgardo Hernandez, President of Lilly Manufacturing, explains the strategy behind the ambitious investment project.

Substances of Concern
The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.

ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.